中老年肺癌患者胸部放疗期间症状群的调查及护理对策

doi:10.3761/j.issn.0254-1769.2023.13.010

摘要/Abstract

摘要：

目的纵向分析中老年肺癌患者不同时期症状群的特点，为制订针对性的症状管理措施提供依据。方法采用前瞻性研究设计，便利选取2021年4月—2022年5月湖北省某三级甲等综合医院肿瘤科的中老年肺癌患者，分别在放疗前1天、放疗前期、放疗后期、放疗结束时，使用安德森症状-修订版肺癌特异模块量表进行调查，对4个时间点症状发生率>20%的症状进行探索性因子分析，并进行统计描述。结果中老年肺癌患者放疗前1天有2个症状群，分别为感知症状群和肺癌特异症状群；放疗前期有4个症状群，分别为感知症状群、放疗症状群、肺癌特异症状群和消化道症状群；放疗后期有3个症状群，分别为放疗症状群、感知症状群和肺癌特异症状群；放疗结束时存在3个症状群，分别为放疗症状群、消化道症状群和感知症状群。结论中老年肺癌患者在放疗期稳定存在多个症状群，群内单症状发生率、严重程度及症状群呈动态变化，护理人员应针对肺癌患者不同放疗时期存在的症状群特征，制订高效、有针对性的护理措施，减轻患者的症状负担。

关键词: 肺癌, 放疗期, 症状群, 纵向研究, 护理

Abstract:

Objective To explore the characteristics of symptom groups in middle-aged and elderly lung cancer patients at different stages，with the aim of providing a basis for developing targeted symptom management in clinical practice. Methods A prospective study design was used to conveniently select middle-aged and elderly lung cancer patients from the oncology department of a tertiary A general hospital in Hubei Province from April 2021 to May 2022. The Chinese version of the Anderson Symptom Scale and lung cancer specific module were used to investigate the symptoms with a symptom incidence rate of ≥ 20% at 4 time points，namely a day before，early stage，later stage and at the end of radiotherapy. Exploratory factor analysis was conducted and statistical descriptions were conducted. Results The results showed that there were 2 symptom groups in middle-aged and elderly lung cancer patients a day before radiotherapy，namely perceived symptom group and lung cancer specific symptom group. There are 4 symptom groups in the early stage of radiotherapy，namely perception symptom group，radiotherapy symptom group，specific symptom group，and digestive symptom group. There are 3 symptom groups in the later stage of radiotherapy，namely radiotherapy symptom group，perceived symptom group，and specific symptom group. At the end of radiotherapy，there are 3 symptom groups，namely radiotherapy symptom group，digestive symptom group，and perceptual symptom group. Conclusion The incidence，severity，and symptom group of symptoms in middle-aged and elderly lung cancer patients show dynamic changes during radiotherapy. We should fully consider the characteristics of symptom groups present at different time points during the patient’s radiotherapy period，and provide efficient and targeted intervention measures.

Key words: Lung Cancer, Radiotherapy Period, Symptom Clusters, Longitudinal Study, Nursing Care

汪燃, 黄菲. 中老年肺癌患者胸部放疗期间症状群的调查及护理对策[J]. 中华护理杂志, 2023, 58(13): 1596-1602.

WANG Ran, HUANG Fei. Longitudinal study on symptom groups of middle-aged and elderly lung cancer patients during chest radiotherapy[J]. Chinese Journal of Nursing, 2023, 58(13): 1596-1602.

图/表 6

表1 调查对象的一般资料（n=124）

Table 1 General information of respondents（n=124）

表2 中老年肺癌患者放疗期不同时间点症状发生率及严重程度（n=124）

Table 2 Incidence and severity of symptoms at all time points during radiotherapy in elderly patients with lung cancer（n=124）

表3 中老年肺癌患者放疗前症状旋转后的因子载荷矩阵（n=124）

Table 3 Factorial loading matrix of elderly patients with lung cancer after symptom rotation before radiotherapy（n=124）

表4 中老年肺癌患者放疗前期症状旋转后的因子载荷矩阵（n=124）

Table 4 Factorial loadings matrix of elderly lung cancer patients after symptom rotation from pre- radiotherapy period（n=124）

表5 中老年肺癌患者放疗后期症状旋转后的因子载荷矩阵（n=124）

Table 5 Factor loadings matrix of symptom rotation after radiotherapy in middle-aged and older patients with lung cancer（n=124）

表6 中老年肺癌患者放疗结束时症状旋转后的因子载荷矩阵（n=124）

Table 6 Factor loadings matrix of symptom rotation at the end of radiotherapy for middle-aged and older patients with lung cancer （n=124）

参考文献 23

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI URL
[2]	梁锌, 刘梦雯, 张丽, 等. 全球部分地区肺癌发病趋势及年龄变化情况分析[J]. 中国肿瘤, 2022, 31(9):683-692.
	Liang X, Liu MW, Zhang L, et al. Global trends of incidence of lung cancer[J]. China Cancer, 2022, 31(9):683-692.
[3]	段和新, 向志碧, 彭海芹, 等. 近十年全球肺癌放疗研究现状及发展趋势[J]. 中华放射肿瘤学杂志, 2020, 29(6):401-406.
	Duan HX, Xiang ZB, Peng HQ, et al. Research status and development trend of global radiotherapy for lung cancer in recent 10 years:bibliometric analysis based on Web of Science[J]. Chin J Radiat Oncol, 2020, 29(6):401-406.
[4]	Gao SG, Li N, Wang SH, et al. Lung cancer in people’s republic of China[J]. J Thorac Oncol, 2020, 15(10):1567-1576. DOI URL
[5]	Kim HJ, McGuire DB, Tulman L, et al. Symptom clusters:concept analysis and clinical implications for cancer nursing[J]. Cancer Nurs, 2005, 28(4):270-284.
[6]	秦莉媛, 侯晓婷, 杨萍. 肺癌患者症状群的研究进展[J]. 中华护理杂志, 2019, 54(1):119-124.
	Qin LY, Hou XT, Yang P. Research progress of symptom groups in patients with lung cancer[J]. Chin J Nurs, 2019, 54(1):119-124.
[7]	Harris CS, Kober KM, Conley YP, et al. Symptom clusters in patients receiving chemotherapy:a systematic review[J]. BMJ Support Palliat Care, 2022, 12(1):10-21. DOI URL
[8]	吴明隆. 问卷统计分析实务:SPSS操作与应用[M]. 重庆: 重庆大学出版社, 2010.
	Wu ML. Practice of questionnaire statistical analysis:SPSS operation and application[M]. Chongqing: Chongqing University Press, 2010.
[9]	Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients:the M.D. Anderson Symptom Inventory[J]. Cancer, 2000, 89(7):1634-1646. DOI PMID
[10]	Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer:the validity and utility of the lung cancer module of the M. D. Anderson symptom inventory[J]. Oncologist, 2011, 16(2):217-227. DOI PMID
[11]	Wang XS, Wang Y, Guo H, et al. Chinese version of the M. D. Anderson Symptom Inventory:validation and application of symptom measurement in cancer patients[J]. Cancer, 2004, 101(8):1890-1901. DOI URL
[12]	臧瑜. 安德森症状评估量表肺癌模块的修订及肺癌患者症状群研究[D]. 广州: 南方医科大学, 2013.
	Zang Y. Revision of lung cancer module of Anderson Symptom Assessment Scale and study on symptom groups of lung cancer patients[D]. Guangzhou: Southern Medical University, 2013.
[13]	Kim BH, Kim JS, Kim KH, et al. Clinical significance of radiation dose-volume parameters and functional status on the patient-reported quality of life changes after thoracic radiotherapy for lung cancer:a prospective study[J]. Radiol Med, 2021, 126(3):466-473. DOI
[14]	Snijders RAH, Brom L, Theunissen M, et al. Update on prevalence of pain in patients with cancer 2022:a systematic literature review and meta-analysis[J]. Cancers(Basel), 2023, 15(3):591.
[15]	宋丽君. 基于患者报告结局的肺癌患者症状负担和症状群研究[D]. 北京: 中国中医科学院, 2022.
	Song LJ. Study on symptom burden and symptom group of lung cancer patients based on patient-reported outcome[D]. Beijing: China Academy of Chinese Medical Sciences, 2022.
[16]	Chen Y, Xu H, Cheng Y, et al. Application value of evidence-based care in patients with lung cancer chemotherapy[J]. Comput Math Methods Med, 2022, 2022:5747712.
[17]	Henshall CL, Allin L, Aveyard H. A systematic review and nar-rative synthesis to explore the effectiveness of exercise-based interventions in improving fatigue,dyspnea,and depression in lung cancer survivors[J]. Cancer Nurs, 2018, 42(4):295-306. DOI URL
[18]	Li JJ, Li JR, Wu JM, et al. Change in symptom clusters peri-operatively in patients with lung cancer[J]. Eur J Oncol Nurs, 2021, 55:102046.
[19]	Gunn L, Gilbert J, Nenclares P, et al. Taste dysfunction following radiotherapy to the head and neck:a systematic review[J]. Radiother Oncol, 2021, 157:130-140. DOI URL
[20]	Alam SR, Zhang PP, Zhang SY, et al. Early prediction of acute esophagitis for adaptive radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2021, 110(3):883-892. DOI URL
[21]	Kurnat-Thoma EL, Graves LY, Billones RR. et al. A concept development for the symptom science model 2.0[J]. Nurs Res, 2022, 71(6):E48-E60. DOI PMID
[22]	陈东亮, 王媛飞, 陆晓敏, 等. 症状科学模型在慢性病护理中的应用进展及启示[J]. 中华护理杂志, 2023, 58(6):751-757. DOI URL
	Chen DL, Wang YF, Lu XM, et al. Application progress and enlightenment of symptom science model in chronic disease nursing care[J]. Chin J Nurs, 2023, 58(6):751-757. DOI URL
[23]	郑改改, 杨巧芳, 殷月, 等. 急性心力衰竭患者入院时及易损期核心症状群的纵向研究[J]. 中华护理杂志, 2022, 57(17):2109-2115. DOI URL
	Zheng GG, Yang QF, Yin Y, et al. The changes of core symptom clusters in patients with acute heart failure during admission and vulnerable phase:a longitudinal study[J]. Chin J Nurs, 2022, 57(17):2109-2115.